AU2020902151A0 - Treatment of coronavirus (2) - Google Patents

Treatment of coronavirus (2)

Info

Publication number
AU2020902151A0
AU2020902151A0 AU2020902151A AU2020902151A AU2020902151A0 AU 2020902151 A0 AU2020902151 A0 AU 2020902151A0 AU 2020902151 A AU2020902151 A AU 2020902151A AU 2020902151 A AU2020902151 A AU 2020902151A AU 2020902151 A0 AU2020902151 A0 AU 2020902151A0
Authority
AU
Australia
Prior art keywords
coronavirus
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020902151A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axelia Oncology Pty Ltd
Original Assignee
Ena Therapeutics Pty Ltd
Filing date
Publication date
Application filed by Ena Therapeutics Pty Ltd filed Critical Ena Therapeutics Pty Ltd
Publication of AU2020902151A0 publication Critical patent/AU2020902151A0/en
Priority to US17/926,886 priority Critical patent/US20230226004A1/en
Priority to AU2021278377A priority patent/AU2021278377A1/en
Priority to PCT/AU2021/050506 priority patent/WO2021237291A1/en
Priority to EP21812594.6A priority patent/EP4157255A4/en
Abandoned legal-status Critical Current

Links

AU2020902151A 2020-05-26 2020-06-26 Treatment of coronavirus (2) Abandoned AU2020902151A0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US17/926,886 US20230226004A1 (en) 2020-05-26 2021-05-26 Treatment of coronavirus
AU2021278377A AU2021278377A1 (en) 2020-05-26 2021-05-26 Treatment of coronavirus
PCT/AU2021/050506 WO2021237291A1 (en) 2020-05-26 2021-05-26 Treatment of coronavirus
EP21812594.6A EP4157255A4 (en) 2020-05-26 2021-05-26 Treatment of coronavirus

Publications (1)

Publication Number Publication Date
AU2020902151A0 true AU2020902151A0 (en) 2020-07-09

Family

ID=

Similar Documents

Publication Publication Date Title
EP4061349A4 (en) Methods of treating coronavirus
EP4117630A4 (en) Treatment of coronavirus infection
EP4096653A4 (en) Compositions for the treatment of angiolipoma
EP4110369A4 (en) Methods of treatment and related compositions
EP4121038A4 (en) Compositions and methods for the treatment of coronavirus infection and respiratory compromise
EP4157255A4 (en) Treatment of coronavirus
EP4168425A4 (en) Methods and compositions for the treatment of muscular dystrophy
EP4138852A4 (en) Compositions and methods for the treatment of pain
EP4135719A4 (en) Treatment of coronavirus infections
AU2020902151A0 (en) Treatment of coronavirus (2)
EP4126038A4 (en) Vaccine compositions for the treatment of coronavirus
EP4132503A4 (en) Methods for treatment of coronavirus infections
EP4146240A4 (en) Methods of treating or preventing coronavirus infection
EP4121025A4 (en) Sphingosine pathway modulating compounds for the treatment of coronavirus infection
EP4120863A4 (en) Method for treatment of coronavirus infection
EP4137130A4 (en) Use of ovatodiolide against novel coronavirus
AU2020902150A0 (en) Coronavirus treatment (2)
EP4096704A4 (en) Therapeutic uses of dulaglutide
AU2020901711A0 (en) Treatment of coronavirus
AU2020901709A0 (en) Coronavirus treatment
GB202014412D0 (en) Treatment of coronavirus
AU2023902382A0 (en) Methods of treatment
AU2022902973A0 (en) Combination therapy (2)
AU2021900740A0 (en) Combination Methods of Treatment
AU2021903030A0 (en) Methods of treatment